Amgen Inc. (AMGN): ‘Absurd That This Stock Sells for 14x Earnings’ – Jim Cramer on Blockbuster Drugs
We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...
Nancy A Grygiel Implements A Sell Strategy: Offloads $483K In Amgen Stock
What Happened: Grygiel's recent move involves selling 1,589 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total ...
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.
Amgen's Broad Portfolio Strength and Wide Moat Should Protect Profits Despite Upcoming Biosimilars
Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...
Mena FN5d
Repatha Global Market Report 2025: An In-Depth Look At Market Sizes, Growth Trends, And Key Industry Players
Repatha evolocumab is a form of treatment for cardiovascular diseases ... Major companies operating in the repatha market include industry giant Amgen Inc. Their significant presence and ...